the most robust metabolic findings are the lowered csf hva in many ts patients , and the positive response of symptoms to dopamine blockers and clonidine particularly , which would be consistent with dopamine receptor hypersensitivity and possible noradrenergic-dopaminergic interactions in ts .
C0009014
clonidine
C0020517
hypersensitivity